HomeInsightsShare Holding

Marksans Pharma Ltd Share Holding Pattern

Marksans Pharma Ltd Share Holding Pattern

stocks purchased

₹ 1.2 Cr

Volume Transacted

(Jan 3, 2025)

stocks purchased

40.3 K

Stocks Traded

(Jan 3, 2025)

Last Updated on: Jan 06, 2025

Promoters Holdings Over Time

Key Highlights

  • Promoters increased their stake in the company by 0.02% from March 2024 to June 2024. FIIs/FPIs increased their stake in the company by 3.02% from March 2024 to June 2024.
  • Mutual funds decreased their stake in the company by 1.41% from March 2024 to June 2024.

Latest Shareholding

Market Price of Marksans Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Marksans Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
03 Jan 2025297.55
02 Jan 2025298
01 Jan 2025304.7
31 Dec 2024296.7
30 Dec 2024287.35
27 Dec 2024293.6
26 Dec 2024290.15
24 Dec 2024293.65
23 Dec 2024293.55
20 Dec 2024303.65

Marksans Pharma Ltd News Hub

News

Marksans Pharma receives USFDA approval for Loratadine Tablets

Marksans Pharma announced the final approval of the Company's Abbreviated New Drug Applica...

Read more

22 Nov 2024 12:47

News

Marksans Pharma gains after receiving final nod for Loratadine Tablets from USFDA

The said drugs are indicated for the treatment of allergic rhinitis caused by pollen and u...

Read more

22 Nov 2024 13:23

News

Marksans Pharma gains after Q2 PAT rises 16% YoY to Rs 97 cr

The firm stated that growth was witnessed across all key markets, led by US and followed b...

Read more

12 Nov 2024 13:22

News

Marksans Pharma to declare Quarterly Result

Marksans Pharma will hold a meeting of the Board of Directors of the Company on 12 Novembe...

Read more

23 Oct 2024 17:41

News

Marksans Pharma announces receipt of UKMHRA approval for Fluoxetine capsules

Marksans Pharma'announced that its wholly owned subsidiary Relonchem has received Marketin...

Read more

21 Aug 2024 20:00

News

Marksans Pharma's Verna unit successfully completes USFDA inspection

Marksans Pharma announced that he USFDA has issued an Establishment Inspection Report (EIR...

Read more

20 Aug 2024 14:37

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Marksans Pharma Ltd

On what factors does the shareholding pattern of Marksans Pharma Ltd change frequently?

The shareholding pattern of Marksans Pharma Ltd can change due to various factors such as stock market transactions, new share issuances, buy-backs, or changes in ownership by institutional and retail investors.

How often is Marksans Pharma Ltd's shareholding pattern updated?

The Marksans Pharma Ltd shareholding pattern is typically updated quarterly or semi-annually, depending on regulatory requirements and internal reporting schedules.

What categories are included in the shareholding pattern of Marksans Pharma Ltd?

Categories included in the shareholding pattern of Marksans Pharma Ltd include promoter/management holdings, institutional investors, retail investors, and others such as foreign investors.

Why is the shareholding pattern of Marksans Pharma Ltd important for investors?

The shareholding pattern of Marksans Pharma Ltd is important for investors as it provides insights into ownership distribution, control dynamics, and the potential influence of major shareholders on company decisions and stock performance.

Where can I find the latest shareholding pattern of Marksans Pharma Ltd?

The latest shareholding pattern of Marksans Pharma Ltd can be found on BlinkX. You may also check the quarterly financial reports, which are available on the company’s official website under the Investor Relations section. Additionally, you can check stock exchange websites like NSE and BSE for the most recent filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions